Crescent Biopharma (CBIO) Change in Cash (2013 - 2026)
Crescent Biopharma (CBIO) reported Change in Cash of -$24.0 million for Q1 2026, down 94.77% year-over-year from -$459.6 million in Q1 2025, and down 130.06% quarter-over-quarter from $79.9 million in Q4 2025.
Crescent Biopharma (CBIO) Change in Cash (2013 - 2026) Analysis & Trends
Crescent Biopharma (CBIO) has 14 years of Change in Cash data on file, last reported at -$24.0 million in Q1 2026.
- Change in Cash for Q1 2026 came in at -$24.0 million, down 94.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $166.8 million (up 1132.79% YoY), and the FY2025 annual result was $178.5 million, up 674.57% from the prior year.
- Change in Cash fell to -$24.0 million in Q1 2026 per CBIO's latest filing, from $79.9 million in the prior quarter.
- Over five years, Change in Cash peaked at $130.3 million in Q2 2025 and troughed at -$24.0 million in Q1 2026.
- A 5-year average of $7.6 million and a median of -$8.6 million in 2022 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2022 and 2025: Change in Cash sank 201.0% in 2022, then soared 1565.05% in 2025.
- A 5-year view of Change in Cash shows it stood at -$3.8 million in 2022, then slumped by 102.84% to -$7.6 million in 2023, then surged by 556.56% to $34.8 million in 2024, then soared by 129.9% to $79.9 million in 2025, then tumbled by 130.06% to -$24.0 million in 2026.
- Business Quant data shows CBIO's Change in Cash at -$24.0 million in Q1 2026, $79.9 million in Q4 2025, and -$19.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -45.97 Mn |
| 10 | Crescent Biopharma | 486.92 Mn | 297.76 Mn | - | -24.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.03 Mn |
| Dec 31, 2025 | 79.93 Mn |
| Sep 30, 2025 | -19.38 Mn |
| Jun 30, 2025 | 130.32 Mn |
| Mar 31, 2025 | -12.34 Mn |
| Dec 31, 2024 | 34.77 Mn |
| Jun 30, 2024 | -8.90 Mn |
| Mar 31, 2024 | -10.51 Mn |
| Dec 31, 2023 | -7.61 Mn |
| Sep 30, 2023 | -8.63 Mn |
| Jun 30, 2023 | -6.97 Mn |
| Mar 31, 2023 | 17.13 Mn |
| Dec 31, 2022 | -3.75 Mn |
| Sep 30, 2022 | -8.62 Mn |
| Jun 30, 2022 | -16.27 Mn |
| Mar 31, 2022 | -13.74 Mn |
| Dec 31, 2021 | -11.67 Mn |
| Sep 30, 2021 | -16.93 Mn |
| Jun 30, 2021 | -13.62 Mn |
| Mar 31, 2021 | -4.56 Mn |